211 related articles for article (PubMed ID: 9568082)
1. Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach.
Imada T; Rino Y; Takahashi M; Shiozawa M; Hatori S; Noguchi Y; Amano T; Kobayashi O; Sairenji M; Motohashi H
Anticancer Res; 1998; 18(1A):231-5. PubMed ID: 9568082
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.
Imada T; Rino Y; Hatori S; Shiozawa M; Takahashi M; Amano T; Kondo J; Kobayashi O; Sairenji M; Motohashi H
Hepatogastroenterology; 2000; 47(34):1186-8. PubMed ID: 11020911
[TBL] [Abstract][Full Text] [Related]
3. Gastric remnant cancer compared with primary proximal gastric cancer.
Inomata M; Shiraishi N; Adachi Y; Yasuda K; Aramaki M; Kitano S
Hepatogastroenterology; 2003; 50(50):587-91. PubMed ID: 12749279
[TBL] [Abstract][Full Text] [Related]
4. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes for early gastric cancer in the upper third of the stomach.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
J Am Coll Surg; 2005 Jan; 200(1):15-9. PubMed ID: 15631915
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment for advanced carcinoma of the gastric remnant.
Isozaki H; Tanaka N; Fujii K; Nomura E; Tanigawa N
Hepatogastroenterology; 1998; 45(23):1896-900. PubMed ID: 9840172
[TBL] [Abstract][Full Text] [Related]
7. Is gastric remnant cancer clinically different from primary gastric cancer?
Lo SS; Wu CW; Hsieh MC; Lui WY
Hepatogastroenterology; 1997; 44(13):299-301. PubMed ID: 9058163
[TBL] [Abstract][Full Text] [Related]
8. Lymph node dissection in surgical treatment for remnant stomach cancer.
Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
[TBL] [Abstract][Full Text] [Related]
9. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
10. Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity?
Newman E; Brennan MF; Hochwald SN; Harrison LE; Karpeh MS
Am J Surg; 1997 Apr; 173(4):292-7. PubMed ID: 9136783
[TBL] [Abstract][Full Text] [Related]
11. The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Popiela T; Kulig J; Kołodziejczyk P;
Przegl Lek; 2000; 57 Suppl 5():9-13. PubMed ID: 11202309
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
13. Early gastric cancer in the remnant stomach.
Takeda J; Toyonaga A; Koufuji K; Kodama I; Aoyagi K; Yano S; Ohta J; Shirozu K
Hepatogastroenterology; 1998; 45(23):1907-11. PubMed ID: 9840174
[TBL] [Abstract][Full Text] [Related]
14. Progression and prognosis of gastric stump cancer.
Hu X; Tian DY; Cao L; Yu Y
J Surg Oncol; 2009 Nov; 100(6):472-6. PubMed ID: 19697396
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
17. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
19. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer.
Deng JY; Liang H; Sun D; Pan Y; Zhang RP; Wang BG; Zhan HJ
Eur J Surg Oncol; 2009 Aug; 35(8):814-9. PubMed ID: 19111430
[TBL] [Abstract][Full Text] [Related]
20. T4 gastric carcinoma: the benefit of non-curative resection.
Kim DY; Joo JK; Seo KW; Park YK; Ryu SY; Kim HR; Kim YJ; Kim SK
ANZ J Surg; 2006 Jun; 76(6):453-7. PubMed ID: 16768767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
